Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.1Niacinamide as the skin active
What ifWhat if the delivery system carried niacinamide as its sole skin active?
Claim language“a retinoid, or derivative thereof”
Niacinamide dissolves in a water and glycerol phase dispersed as droplets in a continuous oil phase. Spreading the emulsion deposits the dissolved niacinamide on the skin, where it supports epidermal barrier function.
1.1Direct deposition of retinoid powder
What ifWhat if the retinoid reached the skin as neat crystalline powder from a metered contact applicator?
Claim language“incorporated in a delivery vehicle”
A sealed applicator meters crystalline retinol onto a contact pad that transfers the particles to the skin. Skin surface lipids dissolve the deposited retinol, and a small metered dose limits the mass transferred per application.
1.2Water rich hydrogel carrier
What ifWhat if the carrier contained 80 wt. % water and formed a hydrogel?
Claim language“no more than about 35 wt. % of water”
Hydroxyethylcellulose thickens a water and glycerol carrier containing 80 wt. % water by carrier weight. The gel suspends retinol-loaded lipid particles, and a preservative system controls microbial growth during storage.
1.2Water continuous lotion carrier
What ifWhat if the carrier contained 65 wt. % water and used an oil-in-water emulsion to spread the active?
Claim language“no more than about 35 wt. % of water”
A nonionic emulsifier and a fatty alcohol stabilize oil droplets in a carrier containing 65 wt. % water by carrier weight. Retinyl palmitate dissolves in the oil droplets, which spread across the skin as the continuous water phase evaporates.
1.3Water added during dispensing
What ifWhat if a two-chamber dispenser produced a personal care composition with 60 wt. % water at the outlet?
Claim language“no more than about 35 wt. % of water”
The dispenser meters an anhydrous retinol concentrate and an aqueous gel containing 90 wt. % water at a mass ratio of one to two. A static mixer disperses the concentrate through the gel to produce an application dose containing 60 wt. % water by total weight.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Hand care at industrial wash stations
An occupational hand care station holds a sealed pump cartridge beside the drying station. The cartridge contains retinyl palmitate in solid lipid particles dispersed in a water-in-oil carrier with 15 wt. % water. After washing and drying, workers dispense the emulsion and spread it over the backs of their hands.
Component substitution
Squalane as the carrier oil
Squalane replaces silicone oil as the continuous phase of the carrier. A polyglyceryl fatty acid ester stabilizes droplets of water and glycerol in the squalane phase, and water accounts for 20 wt. % of the finished composition. Retinyl palmitate is incorporated in solid lipid particles, which are stirred into the emulsion after it cools to 30 °C.
Cyclodextrin as the retinoid vehicle
Beta-cyclodextrin replaces lipid particles as the delivery vehicle for retinol. Retinol in ethanol is mixed with an aqueous beta-cyclodextrin solution, and the precipitated inclusion complex is filtered, dried under vacuum, and milled. The powder is dispersed in an oil-continuous cream whose carrier and finished composition each contain less than 25 wt. % water. Moisture at the application site wets the particles, and released retinol partitions into the surface oils.
Parameter or scale variation
Two particle sizes in one cream
Retinyl palmitate is incorporated in glyceryl behenate particles in two size fractions, one at 15–30 µm and the other at 60–90 µm. Separate spray-congealing runs produce the fractions, which are sieved and blended at a 1:1 particle mass ratio. The blend is stirred into a water-in-oil carrier containing 20 wt. % water. At equal particle mass and lipid composition, the smaller fraction provides more surface area for transfer of retinyl palmitate into the surrounding oil.
Combination with existing systems
Retinoid reservoir in a skin patch
A flexible patch contains a cream reservoir between an opaque backing and a porous skin-contact membrane. The cream contains retinyl palmitate in solid lipid particles and has 15 wt. % water, with the carrier also below 35 wt. % water. A perimeter adhesive holds the membrane against the skin, and the wetted membrane provides a diffusion path from the reservoir to the skin surface.
Automated or data-driven variant
Moisture control during batch mixing
A batch mixer incorporates retinoid-loaded lipid particles into a water-in-oil carrier and recirculates the mixture past an inline near-infrared probe. The controller estimates water content from spectra calibrated against water measurements on samples of the same formulation. It meters water to a 20 wt. % carrier setpoint before particle addition and releases the finished batch for filling when its water estimate stabilizes within 18–22 wt. %.
Specific version of a part
Retinol in lipid microparticles
Retinol dissolves in a molten mixture of glyceryl behenate and caprylic and capric triglycerides. Cooling the dispersed melt forms lipid microparticles that hold retinol in the lipid matrix.
Retinol in cyclodextrin cavities
Beta-cyclodextrin binds retinol within its hydrophobic cavity to form an inclusion complex. The dried complex disperses as a powder in a low-water carrier and releases retinol as skin moisture hydrates the particles.
Low water inverse emulsion
The carrier contains 20 wt. % water by carrier weight, with glycerol dissolved in the dispersed water droplets. A low hydrophilic-lipophilic balance emulsifier stabilizes the droplets in a continuous triglyceride oil phase.
Finished cream water balance
A finished cream contains 80 wt. % carrier with 30 wt. % water and 20 wt. % lipid delivery dispersion with 10 wt. % water. The carrier contributes 24 percentage points and the dispersion contributes two, giving 26 wt. % water by total composition weight.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1a delivery system comprising a retinoid, or derivative thereof, incorporated in a delivery vehicle; and
Although the specifically enabling embodiments disclosed herein suggest the use of jojoba ester beads as the delivery vehicle for improving the availability of bio-available compounds, any anhydrous particle formulation, whether now known or otherwise hereafter described in the art, may be alternatively, conjunctively or sequentially employed; including for example: ethylhexyl palmitate, petrolatum (VASELINE), polyethylene, and/or the like.
A · US 2006/0188533 A1 · ¶ 39
1.2a cosmetically acceptable carrier comprising no more than about 35 wt. % of water;
Jojoba ester compositions have been found to function well as a dry (e.g., anhydrous) carriers or vehicles for the application of active materials to the skin or hair of consumers.
A · US 2006/0188533 A1 · ¶ 12
For purposes of the invention, an “anhydrous carrier medium” is a substance that is substantially free of water. “Substantially free of water” means that water that is present, if any, is in insufficient amount to affect either percutaneous absorption or the activity or stability of the bioactive substance.
B · US 7,241,456 B2 · ¶ 21
1.3wherein the personal care composition comprises no more than about 35 wt. % of water, based on a total weight of the personal care composition.
A formulation for topical application comprising an anhydrous carrier medium, micronized niacin and a micronized anti-inflammatory agent selected from the group consisting of aspirin, ibuprofen, acetaminophen and cox-2 inhibitors, an enzymatic exfolient and a penetration enhancer, wherein the formulation is substantially free of water.
B · US 7,241,456 B2 · claim 1
An empty cell means only that no passage was reproduced there.
Statements in these documents
Conventional options for providing topical formulations containing bio-available compounds are limited due to unrefined methods of delivery and poor delivery transport kinetics.
A · US 2006/0188533 A1 · ¶ 3
Additionally, traditional methods do not afford effective substantially anhydrous delivery of bio-formulations that are otherwise unstable in the presence of water, such as Vitamin C (ascorbic acid).
A · US 2006/0188533 A1 · ¶ 3
There is, therefore, a need for new formulations that allow efficient topical delivery of high concentrations of underivitized bioactive substances for percutaneous absorbtion.
B · US 7,241,456 B2 · ¶ 5
The invention provides formulations that allow efficient topical delivery of high concentrations of bioactive substances for percutaneous absorption.
B · US 7,241,456 B2 · ¶ 6
Cite aspatent.fyi, US 2026/0355091 A1, claim 1, first published 2026-11-19T07:53:10-05:00, https://patent.fyi/US20260355091/, SHA-256 51e96cce4001118797ca1fc2463e4696fc7d5ed1b904518c71e876c638baf40a